Rheumatology, geriatrics, and a way forward

Journal of the American Geriatrics Society

Volumn 50, Issue 10, 2002, Pages 1737-1738

  Studenski, Stephanie A ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

AGING; ARTHRITIS; CLINICAL RESEARCH; CORTICOSTEROID THERAPY; GERIATRIC PATIENT; HUMAN; NOTE; OUTCOMES RESEARCH; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; AGED; ARTHRITIS, RHEUMATOID; GERIATRICS; HISTORY, 20TH CENTURY; HUMANS; RHEUMATOLOGY;

EID: 0036800586     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50473.x     Document Type: Note

References (30)

1. Montgomery MM, Zivin S, Steck IE. Certain aspects of ACTH and cortisone therapy in older patients with rheumatoid arthritis. J Am Geriatr Soc 1953;1:9-16.
2. Hensch PS, Kendall EC, Slocumb CH et al. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of the pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proceedings of Staff Meeting. Mayo Clin Proc 1949;24:181-197.
3. Hensch PS, Kendall EC, Slocumb CH et al. Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions: A study in clinical physiology. Arch Intern Med 1950;85:546-566.
4. Calkins E. Management of rheumatoid arthritis and other autoimmune rheumatic diseases. In: Hazzard WR, Blass JP, Ettinger WH et al., eds. Principles of Geriatrics and Gerontology, 4th Ed. New York, NY: McGraw Hill, 1999, pp 1135-1153.
5. Gruenewald DA, Matsumoto AM. Aging of the endocrine system. In: Hazzard WR, Blass JP, Ettinger WH et al. eds. Principles of Geriatrics and Gerontology, 4th Ed. New York, NY: McGraw Hill, 1999, pp 955-957.
6. Morand EF, Leech M. Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis. Immunol Cell Biol 2001;79:395-399.
7. Kuiper S, Van Gestel AM, Swinkels HL et al. Influence of sex, age and menopausal state on the course of early rheumatoid arthritis. J Rheumatol 2001;28:1809-1816.
8. Traut EF. Rheumatic Diseases. St. Louis, MO: CV Mosby, 1952, pp 719-742.
9. Cecil RL, Loeb RF, eds. A Textbook of Medicine. Philadelphia, PA: WB Saunders Co., 1955, pp 1417-1429.
10. Wolfe F. 50 years of antirheumatic therapy: The prognosis of rheumatoid arthritis. J Rheumatol 1990;17(Suppl 22):24-32.
11. Moreland LW, Russell AS, Paulus HE. Management of rheumatoid arthritis: The historical context. J Rheumatol 2001;28:1431-1452.
12. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: The health assessment questionnaire, disability and pain scale. J Rheumatol 1982;9:789-793.
13. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987. Revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
14. Hochberg MC, Chang RW, Dwosh I et al. The American College of Rheumatology 1991. Revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992;35:498-502.
15. Felson DT, Anderson JJ, Boers M et al. The American College of Rheumatology. Preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-740.
16. Felson DT, Anderson JJ, Boers M et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-735.
17. Felson DT, Anderson JJ, Lange MLM et al. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures rather than twenty percent? Arthritis Rheum 1998;42:1564-1570.
18. Wolfe F, Cush JJ, O'Dell JR et al. Consensus recommendations for the assessment and treatment of rheumatoid arthritis. J Rheumatol 2001;28:1423-1430.
19. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001;358:903-911.
20. Gotzsche PC, Johansen HK. Short-Term Low-Dose Corticosteroids Vs Placebo and Nonsteroidal Antiinflammatory Drugs in Rheumatoid Arthritis (Cochrane Review). The Cochrane Library 1. Oxford, UK: Update Software, 2002.
21. Van Everdingen AA, Jacobs JWG, van Reeseama DRS et al. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease modifying properties and side effects. Ann Intern Med 2002;136:1-12.
22. Gabriel SE, Crowson CS, O'Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum 1999;42:415-420.
23. Maini RN, Breedveld FC, Kalden J et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low dose of weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-1563.
24. Weinblatt ME, Kremer JM, Bankhurst AD et al. Trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999;340:253-259.
25. Maini R, St Clair EW, Breedveld F et al. Infliximab (chimeric anti-tumor necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomized phase III trial. Lancet 1999;354:1932-1939.
26. Moreland LW, Schiff MH, Baumgartner SW et al. Etanercept therapy in rheumatoid arthritis. Ann Intern Med 1999;130:478-486.
27. Strand V, Cohen S, Schiff M et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 1999;159:2542-2550.
28. Smolen JS, Kalden JR, Scott DL et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind randomized multicentre trial. Lancet 1999;353:259-266.
29. Lipsky PR, Van derHeijde DMFM, St. Clair EW et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-1602.
30. Bathon JM, Martin RW, Fleischmann RM et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586-1593.